ATE342962T1 - Zusammensetzungen und verfahren für verbesserte zellkultur - Google Patents

Zusammensetzungen und verfahren für verbesserte zellkultur

Info

Publication number
ATE342962T1
ATE342962T1 AT00959455T AT00959455T ATE342962T1 AT E342962 T1 ATE342962 T1 AT E342962T1 AT 00959455 T AT00959455 T AT 00959455T AT 00959455 T AT00959455 T AT 00959455T AT E342962 T1 ATE342962 T1 AT E342962T1
Authority
AT
Austria
Prior art keywords
cell culture
methods
compositions
improved cell
igf
Prior art date
Application number
AT00959455T
Other languages
English (en)
Inventor
Arvia E Morris
Pranhitha Reddy
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Application granted granted Critical
Publication of ATE342962T1 publication Critical patent/ATE342962T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/0043—Medium free of human- or animal-derived components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/005—Protein-free medium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/105—Insulin-like growth factors [IGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT00959455T 1999-08-25 2000-08-25 Zusammensetzungen und verfahren für verbesserte zellkultur ATE342962T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15064599P 1999-08-25 1999-08-25
US16894899P 1999-12-03 1999-12-03
US17194999P 1999-12-23 1999-12-23

Publications (1)

Publication Number Publication Date
ATE342962T1 true ATE342962T1 (de) 2006-11-15

Family

ID=27387011

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00959455T ATE342962T1 (de) 1999-08-25 2000-08-25 Zusammensetzungen und verfahren für verbesserte zellkultur

Country Status (14)

Country Link
US (3) US6413744B1 (de)
EP (1) EP1210411B1 (de)
JP (1) JP2003507058A (de)
AT (1) ATE342962T1 (de)
AU (1) AU784506B2 (de)
CA (1) CA2383073A1 (de)
CY (1) CY1105772T1 (de)
DE (1) DE60031419T2 (de)
DK (1) DK1210411T3 (de)
ES (1) ES2272318T3 (de)
IL (2) IL148060A0 (de)
NZ (2) NZ517215A (de)
PT (1) PT1210411E (de)
WO (1) WO2001014529A1 (de)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6475725B1 (en) 1997-06-20 2002-11-05 Baxter Aktiengesellschaft Recombinant cell clones having increased stability and methods of making and using the same
US7115231B1 (en) 1998-06-09 2006-10-03 Symyx Technologies, Inc. Parallel reactor with knife-edge seal
AT409379B (de) 1999-06-02 2002-07-25 Baxter Ag Medium zur protein- und serumfreien kultivierung von zellen
US6413744B1 (en) * 1999-08-25 2002-07-02 Immunex Corporation Methods and host cells for improved cell culture
IL136232A0 (en) * 2000-05-18 2001-05-20 Bar Ilan University Res Author Measurements of enzymatic activity in a single, individual cell in population
US6455007B1 (en) 2000-06-13 2002-09-24 Symyx Technologies, Inc. Apparatus and method for testing compositions in contact with a porous medium
US6439036B1 (en) 2000-06-13 2002-08-27 Symyx Technologics, Inc. Method for evaluating a test fluid
US7018589B1 (en) 2000-07-19 2006-03-28 Symyx Technologies, Inc. High pressure parallel reactor
US7091004B1 (en) 2001-06-08 2006-08-15 Immunex Corporation Regulation of translation for recombinant protein production
US20050271663A1 (en) * 2001-06-28 2005-12-08 Domantis Limited Compositions and methods for treating inflammatory disorders
US20060073141A1 (en) * 2001-06-28 2006-04-06 Domantis Limited Compositions and methods for treating inflammatory disorders
EP1806407B1 (de) 2001-07-04 2010-05-05 Chromagenics B.V. DNS-Sequenzen mit Anti-Repressor-Aktivität
EP2332651A3 (de) * 2001-10-25 2011-08-31 Bar Ilan University Interaktiver transparenter Biochip-Prozessor für einzeln adressierbare Zellen
US20030166147A1 (en) * 2001-12-14 2003-09-04 Lee Chichang Clonal myeloma cell lines useful for manufacturing proteins in chemically defined media
CA2491992A1 (en) 2002-07-09 2004-01-15 Baxter International, Inc. Animal protein free media for cultivation of cells
ATE354645T1 (de) * 2002-12-20 2007-03-15 Chromagenics Bv Mittel und methoden zur produktion eines proteins durch chromatin-öffner, die chromatin zugänglicher für transkriptionsfaktoren machen können
IL154677A0 (en) * 2003-02-27 2003-09-17 Univ Bar Ilan A method and apparatus for manipulating an individual cell
US9200245B2 (en) 2003-06-26 2015-12-01 Seng Enterprises Ltd. Multiwell plate
US7888110B2 (en) 2003-06-26 2011-02-15 Seng Enterprises Ltd. Pico liter well holding device and method of making the same
US8597597B2 (en) * 2003-06-26 2013-12-03 Seng Enterprises Ltd. Picoliter well holding device and method of making the same
WO2004113492A1 (en) * 2003-06-26 2004-12-29 Molecular Cytomics Ltd. Improved materials for constructing cell-chips, cell-chip covers, cell-chip coats, processed cell-chips and uses thereof
WO2005008626A1 (en) * 2003-07-11 2005-01-27 University Of North Carolina At Chapel Hill Methods and systems for controlling a computer using a video image and for combining the video image with a computer desktop
US20050064524A1 (en) * 2003-08-11 2005-03-24 Mordechai Deutsch Population of cells utilizable for substance detection and methods and devices using same
BRPI0506610A (pt) * 2004-02-03 2007-05-02 Chemagis Ltd montelucaste sódico amorfo, processo de preparação de montelucaste sódico amorfo, composição farmacêutica, método de tratamento utilizando a administração de montelucaste sódico amorfo, co-precipitado amorfo de montelucaste sódico e processo de preparação de co-precipitado amorfo de montelucaste sódico
US20080063251A1 (en) * 2004-07-07 2008-03-13 Mordechai Deutsch Method and Device for Identifying an Image of a Well in an Image of a Well-Bearing
US7403647B2 (en) * 2004-09-13 2008-07-22 Seng Enterprises Ltd. Method for identifying an image of a well in an image of a well-bearing component
WO2006021959A2 (en) * 2004-08-25 2006-03-02 Seng Enterprises Ltd. Method and device for isolating cells
ATE517176T1 (de) * 2004-10-15 2011-08-15 Monell Chemical Senses Centre Verfahren zur kultivierung von geschmackszellen aus säugern
US20060094104A1 (en) 2004-10-29 2006-05-04 Leopold Grillberger Animal protein-free media for cultivation of cells
US8999667B2 (en) * 2004-11-08 2015-04-07 Chromagenics B.V. Selection of host cells expressing protein at high levels
US20060195935A1 (en) 2004-11-08 2006-08-31 Chromagenics B.V. Selection of host cells expressing protein at high levels
CN101090968B (zh) 2004-11-08 2011-10-26 科罗迈吉尼科斯公司 高水平表达蛋白质的宿主细胞的选择
US20100136616A1 (en) * 2004-11-08 2010-06-03 Chromagenics B.V. Selection of Host Cells Expressing Protein at High Levels
PL1809750T3 (pl) * 2004-11-08 2012-08-31 Chromagenics Bv Selekcja komórki gospodarza eksprymującej białko na wysokich poziomach
DE602005023534D1 (de) * 2005-01-25 2010-10-21 Seng Entpr Ltd Mikrofluidische vorrichtung zur untersuchung zellen
JP2008527980A (ja) * 2005-01-25 2008-07-31 アポロ ライフ サイエンシズ リミテッド 分子およびそのキメラ分子
EP1707634A1 (de) * 2005-03-29 2006-10-04 Octapharma AG Verfahren zur Isolierung von rekombinant hergestellten Proteinen
US20060232821A1 (en) * 2005-04-15 2006-10-19 Sridharan Ranganathan Parallel architecture for vector color error diffusion
WO2007002210A2 (en) * 2005-06-20 2007-01-04 Bresagen, Inc. Embryonic stem cell culture compositions and methods of use thereof
EP1739179A1 (de) * 2005-06-30 2007-01-03 Octapharma AG Serumfreie stabile Transfektion und Produktion von rekombinanten humanen Proteinen in humanen Zelllinien
DE102005034043B4 (de) * 2005-07-18 2019-12-12 Südzucker Aktiengesellschaft Mannheim/Ochsenfurt Gemisch, enthaltend L-Carnitin und Trehalulose, sowie Produkt enthaltend das Gemisch
US20070141555A1 (en) * 2005-10-11 2007-06-21 Mordechai Deutsch Current damper for the study of cells
WO2007052245A1 (en) * 2005-11-03 2007-05-10 Seng Enterprises Ltd. Method and device for studying floating, living cells
SI2522717T1 (sl) 2006-01-04 2014-05-30 Baxter International Inc. Mediji celične kulture brez oligopeptidov
US20060223999A1 (en) * 2006-05-10 2006-10-05 Chemagis Ltd. Process for preparing montelukast and precursors thereof
US7807109B2 (en) 2007-05-14 2010-10-05 Freeslate, Inc. Parallel batch reactor with pressure monitoring
US7655191B2 (en) 2007-05-14 2010-02-02 Symyx Solutions, Inc. Methods for chemical reactions in a parallel batch reactor
NZ580530A (en) * 2007-06-06 2012-04-27 Domantis Ltd Anti vegf polypeptides, antibody variable domains and antagonists
RU2010102810A (ru) * 2007-06-29 2011-08-10 Ф.Хоффманн-Ля Рош Аг (Ch) Клетки сно
ES2695999T3 (es) * 2007-10-12 2019-01-11 Hoffmann La Roche Expresión de proteínas a partir de múltiples ácidos nucleicos
US9145540B1 (en) 2007-11-15 2015-09-29 Seng Enterprises Ltd. Device for the study of living cells
US9975118B2 (en) 2007-11-15 2018-05-22 Seng Enterprises Ltd. Device for the study of living cells
US8563303B2 (en) * 2008-03-19 2013-10-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Method for increasing recloning efficiency
EP2342318A1 (de) * 2008-09-26 2011-07-13 Schering Corporation Antikörperproduktion mit hohem titer
CN102770458A (zh) * 2009-12-02 2012-11-07 阿塞勒隆制药公司 用于增加Fc融合蛋白的血清半寿期的组合物和方法
PT2673296T (pt) 2011-02-07 2019-01-31 Cerenis Therapeutics Holding Sa Complexos de lipoproteínas e sua fabricação e utilização
EP2718328A4 (de) 2011-06-08 2014-12-24 Acceleron Pharma Inc Zusammensetzungen und verfahren zur erhöhung der halbwertszeit von serum
JP2015531244A (ja) 2012-10-15 2015-11-02 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ タンパク質を製造するための哺乳動物細胞培養方法
EP3022293A4 (de) * 2013-07-19 2017-03-08 Danmarks Tekniske Universitet Verfahren zur modellierung des zellstoffwechsels von ovarien des chinesischen hamsters (cho)
EA035412B1 (ru) 2015-05-29 2020-06-10 Бристол-Майерс Сквибб Компани Антитела к ox40 и их применение
CN113493770A (zh) * 2020-03-18 2021-10-12 苏州大学 人源glut5稳定转染细胞株及其在筛选glut5抑制剂中的应用
JP2024503239A (ja) 2020-12-22 2024-01-25 アムジェン インコーポレイテッド 細胞培養法
US20250230215A1 (en) * 2021-11-08 2025-07-17 Memorial Sloan-Kettering Cancer Center Immune cells expressing glucose transporter 5 (glut5) and compositions and methods including the same

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL87737A (en) 1987-09-11 1993-08-18 Genentech Inc Method for culturing polypeptide factor dependent vertebrate recombinant cells
WO1991003554A1 (en) * 1989-09-01 1991-03-21 Genentech, Inc. Cells transfected with nucleic acid encoding gtp
US5605690A (en) * 1989-09-05 1997-02-25 Immunex Corporation Methods of lowering active TNF-α levels in mammals using tumor necrosis factor receptor
US5283173A (en) * 1990-01-24 1994-02-01 The Research Foundation Of State University Of New York System to detect protein-protein interactions
EP0496453A1 (de) 1991-01-23 1992-07-29 Merck & Co. Inc. Menschlicher glut4 Genpromotor
US5262308A (en) * 1992-01-28 1993-11-16 Thomas Jefferson University Cell lines which constitutively express IGF-1 and IGF-1 R
EP0633934A1 (de) 1992-04-02 1995-01-18 Imperial Cancer Research Technology Limited Modifizierte Zellen und Behandlungsverfahren
US5663314A (en) 1992-11-20 1997-09-02 The Board Of Regents Of The University Of Washington Human signal transduction MAPK kinase
EP0666312A1 (de) 1994-02-08 1995-08-09 Wolfgang A. Renner Verfahren zur Förderung des Wachstums von Säugetierzellen
US5597719A (en) * 1994-07-14 1997-01-28 Onyx Pharmaceuticals, Inc. Interaction of RAF-1 and 14-3-3 proteins
AUPN442295A0 (en) 1995-07-26 1995-08-17 Commonwealth Scientific And Industrial Research Organisation Regulated autocrine growth of mammalian cells
WO1999016887A2 (en) 1997-09-26 1999-04-08 Onyx Pharmaceuticals, Inc. Compositions and methods for identifying pkb kinase inhibitors
US6413744B1 (en) * 1999-08-25 2002-07-02 Immunex Corporation Methods and host cells for improved cell culture

Also Published As

Publication number Publication date
EP1210411A1 (de) 2002-06-05
IL148060A0 (en) 2002-09-12
NZ517215A (en) 2004-01-30
IL148060A (en) 2009-07-20
EP1210411B1 (de) 2006-10-18
DE60031419T2 (de) 2007-09-27
WO2001014529A1 (en) 2001-03-01
WO2001014529A9 (en) 2002-09-06
CA2383073A1 (en) 2001-03-01
US6413744B1 (en) 2002-07-02
US6897040B2 (en) 2005-05-24
DK1210411T3 (da) 2007-02-19
NZ529329A (en) 2005-06-24
AU7077800A (en) 2001-03-19
US7166445B2 (en) 2007-01-23
AU784506B2 (en) 2006-04-13
JP2003507058A (ja) 2003-02-25
ES2272318T3 (es) 2007-05-01
CY1105772T1 (el) 2011-02-02
DE60031419D1 (de) 2006-11-30
PT1210411E (pt) 2006-12-29
US20020160455A1 (en) 2002-10-31
US20050170462A1 (en) 2005-08-04

Similar Documents

Publication Publication Date Title
DE60031419D1 (de) Zusammensetzungen und verfahren für verbesserte zellkultur
MY148759A (en) Methods to culture circovirus
DE60144145D1 (de) Subtilisin-variante
ATE448322T1 (de) Erhöhte in vitro-synthese von aktiven, disulfidbrücken-enthaltenden proteinen
SG149061A1 (en) Definitive endoderm
ZA200405388B (en) Binding proteins as biosensors
SG152273A1 (en) Pdx1 expressing endoderm
EA200401591A1 (ru) Керамические аноды и способ их изготовления
PT1428878E (pt) Processo para a produção e purificação de eritropoietina
DE69942459D1 (de) Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung
DE502004008542D1 (de) Verfahren zur reklonierung von produktionszellen
EP1649006A4 (de) Exo-spezifische amylase-polypeptide, diese polypeptide codierende nukleinsäuren und verwendungen davon
ATE549395T1 (de) Medium und kultur von embryonalen stammzellen
DE60230858D1 (de) Chemisch definiertes medium für kultivierte säugerzellen
DE502006007198D1 (de) Verfahren zur herstellung von permanenten humanen zelllinien
ATE364695T1 (de) Gekürzte lösliche typ-i-rezeptoren für tumor- nekrose-faktor
ATE450603T1 (de) Polypeptide mit verzweigungsenzym-aktivität und für diese kodierende nukleinsäuren
ATA165999A (de) Medium zur protein- und serumfreien kultivierung von zellen
UA92157C2 (ru) Способ продуцирования гормона роста
DE60033918D1 (de) Polysubstituted 6-phenylphenanthridines mit pde-iv hemmender wirkung
IL152406A0 (en) Anti-freeze proteins, their production and use
ATE486128T1 (de) Zusammensetzungen und verfahren zur erhöhung der produktion rekombinanter gamma-carboxylierter proteine
ES2181897T3 (es) Composicion enzimatica.
AU2027001A (en) Method for cell adhesion and wound healing
ATE398169T1 (de) Verfahren zur reinigung von oozysten mittels enzymatischer verdauung von faeces

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1210411

Country of ref document: EP

REN Ceased due to non-payment of the annual fee